BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 21184128)

  • 41. Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond.
    Chai X; Zeng S; Xie W
    Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):253-66. PubMed ID: 23327618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen.
    Lewis DF; Ioannides C; Parke DV
    Environ Health Perspect; 1998 Oct; 106(10):633-41. PubMed ID: 9755138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of gene knockout and transgenic mice in the study of xenobiotic metabolism.
    Gonzalez FJ
    Drug Metab Rev; 2003 Nov; 35(4):319-35. PubMed ID: 14705864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.
    Hatagima A
    Cad Saude Publica; 2002; 18(2):357-77. PubMed ID: 11923879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer therapy and polymorphisms of cytochromes P450.
    MacLeod SL; Nowell S; Massengill J; Jazieh A; McClure G; Plaxco J; Kadlubar FF; Lan NP
    Clin Chem Lab Med; 2000 Sep; 38(9):883-7. PubMed ID: 11097344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Multifarious Link between Cytochrome P450s and Cancer.
    Alzahrani AM; Rajendran P
    Oxid Med Cell Longev; 2020; 2020():3028387. PubMed ID: 31998435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comprehensive analysis and functional characterization of naturally occurring non-synonymous variants of nuclear receptor PXR.
    Rana M; Devi S; Gourinath S; Goswami R; Tyagi RK
    Biochim Biophys Acta; 2016 Sep; 1859(9):1183-1197. PubMed ID: 26962022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of CAR and PXR in xenobiotic sensing and metabolism.
    Wang YM; Ong SS; Chai SC; Chen T
    Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):803-17. PubMed ID: 22554043
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibodies and multifunctional cytochrome P450: drug metabolism as paradigm.
    Gelboin HV; Krausz K
    J Clin Pharmacol; 2006 Mar; 46(3):353-72. PubMed ID: 16490812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study of P450 function using gene knockout and transgenic mice.
    Gonzalez FJ; Kimura S
    Arch Biochem Biophys; 2003 Jan; 409(1):153-8. PubMed ID: 12464254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
    Guengerich FP
    Chem Res Toxicol; 2017 Jan; 30(1):2-12. PubMed ID: 27472660
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection.
    Sonoda J; Rosenfeld JM; Xu L; Evans RM; Xie W
    Curr Drug Metab; 2003 Feb; 4(1):59-72. PubMed ID: 12570746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of cytochrome P450 by posttranslational modification.
    Aguiar M; Masse R; Gibbs BF
    Drug Metab Rev; 2005; 37(2):379-404. PubMed ID: 15931769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymorphism of cytochrome P450 and xenobiotic toxicity.
    Ingelman-Sundberg M
    Toxicology; 2002 Dec; 181-182():447-52. PubMed ID: 12505350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial P450s.
    Omura T
    Chem Biol Interact; 2006 Oct; 163(1-2):86-93. PubMed ID: 16884708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytochrome P450 polymorphisms as risk factors for steroid hormone-related cancers.
    Friedberg T
    Am J Pharmacogenomics; 2001; 1(2):83-91. PubMed ID: 12174676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Xenobiotic metabolism and disposition in human lung: transcript profiling in non-tumoral and tumoral tissues.
    Leclerc J; Courcot-Ngoubo Ngangue E; Cauffiez C; Allorge D; Pottier N; Lafitte JJ; Debaert M; Jaillard S; Broly F; Lo-Guidice JM
    Biochimie; 2011 Jun; 93(6):1012-27. PubMed ID: 21376776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Importance of influx and efflux systems and xenobiotic metabolizing enzymes in intratumoral disposition of anticancer agents.
    Rochat B
    Curr Cancer Drug Targets; 2009 Aug; 9(5):652-74. PubMed ID: 19686091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Transcriptional Regulatory Network Containing Nuclear Receptors and Long Noncoding RNAs Controls Basal and Drug-Induced Expression of Cytochrome P450s in HepaRG Cells.
    Chen L; Bao Y; Piekos SC; Zhu K; Zhang L; Zhong XB
    Mol Pharmacol; 2018 Jul; 94(1):749-759. PubMed ID: 29691280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.